|
DYM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33060000000007E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.564760E-04 |
| Normal-vs-Stage2 |
1.062000E-01 |
| Normal-vs-Stage3 |
1.11369999999944E-06 |
| Normal-vs-Stage4 |
6.569600E-04 |
| Stage1-vs-Stage2 |
1.211820E-01 |
| Stage1-vs-Stage3 |
1.151030E-01 |
| Stage1-vs-Stage4 |
5.534800E-01 |
| Stage2-vs-Stage3 |
1.025850E-02 |
| Stage2-vs-Stage4 |
9.156100E-02 |
| Stage3-vs-Stage4 |
6.275400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94350000004562E-06 |
| Normal-vs-AfricanAmerican |
2.224800E-01 |
| Normal-vs-Asian |
2.019300E-04 |
| Caucasian-vs-AfricanAmerican |
5.977900E-02 |
| Caucasian-vs-Asian |
6.782800E-01 |
| AfricanAmerican-vs-Asian |
4.297700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.34770000000695E-05 |
| Normal-vs-Female |
8.36430000000776E-05 |
| Male-vs-Female |
3.759200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.175900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.57640000000947E-06 |
| Normal-vs-Age(61-80Yrs) |
5.882100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.588360E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.161800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.236400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.512600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.539700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.538400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.886830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.499400E-03 |
| Classical-VS-Follicular |
5.473600E-02 |
| Classical-VS-Other |
4.422400E-01 |
| Classical-VS-Normal |
1.54363000000046E-05 |
| Tall-VS-Follicular |
5.433500E-04 |
| Tall-VS-Other |
7.285600E-01 |
| Tall-VS-Normal |
4.5429999995239E-07 |
| Follicular-VS-Other |
2.442800E-01 |
| Follicular-VS-Normal |
8.262000E-02 |
| Other-VS-Normal |
2.739700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.569100E-04 |
| Normal-vs-N1 |
4.17230000004931E-06 |
| N0-vs-N1 |
1.423870E-02 |
|
|
